Nuwellis Inc. (NUWE)

Name: Nuwellis Inc. (NUWE) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Nuwellis Inc. (NUWE)

Stock Card

$0.89

$-0.10 (-10.12%)

As on 28-Aug-2026 16:27EDT

Market cap

$3 Mln

Revenue (TTM)

$9 Mln

P/E Ratio

P/B Ratio

0.2

Div. Yield

0 %

Nuwellis (NUWE) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.87 High: 1.05

52 Week Range

Low: 0.08 High: 6.40

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-6.1 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-0.3
Debt to Equity

0
Book Value

$-3.6
EPS

$-151.8
Face value

--
Shares outstanding

3,175,134

10 Years Aggregate

CFO

$-172.31 Mln

EBITDA

$-179.21 Mln

Net Profit

$-186.64 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Nuwellis (NUWE)	-48.9	-55.3	17.3	-82.7	-92.7	-93.3	-91.1
BSE Sensex^*	-9.2	-1.3	2.8	-3.7	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Nuwellis (NUWE)	-96.3	-94.4	-94.6	-90.6	-83.6	709.3	-87.4
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Nuwellis (NUWE)	0.9	2.8	9.0	-11.1	-69.8	--	0	0.2
10X Genomics Inc (TXG)	61.5	8,018.1	616.9	-75.1	1.7	-9.3	--	10.2
Avantor (AVTR)	14.6	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	57.1	8,696.7	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	179.9	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.8	6,577.5	1,556.3	275.3	24.6	22.9	24.1	5.0
Merit Medical Systems (MMSI)	90.5	5,403.2	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	321.7	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	176.3	9,947.9	785.1	41.5	9.9	2	251.8	4.9

Shareholding Pattern

View Details

About Nuwellis (NUWE)

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from... fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Read more

President, CEO & Director

Mr. Nestor Jaramillo Jr.
President, CEO & Director

Mr. Nestor Jaramillo Jr.
Headquarters

Eden Prairie, MN
Website

https://www.nuwellis.com

FAQs for Nuwellis (NUWE)

What is the current share price of Nuwellis Inc (NUWE) Today?

The share price of Nuwellis Inc (NUWE) is $0.89 (NASDAQ) as of 28-Aug-2026 16:27 EDT. Nuwellis Inc (NUWE) has given a return of -92.71% in the last 3 years.

What is the current PB & PE ratio of Nuwellis Inc (NUWE)?

Since, TTM earnings of Nuwellis Inc (NUWE) is negative, P/E ratio is not available.
The P/B ratio of Nuwellis Inc (NUWE) is 0.18 times as on 28-Aug-2026, a 95 discount to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.